Birinyi Associates’s Gilead Sciences GILD Stock Holding History

Birinyi Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$223K	Sell	1,600 -361	-18%	-$50.6K	0.06%	59
2025 Q4	$241K	Buy	+1,961	New	+$238K	0.06%	57
2016 Q3	–	Sell	-6,350	Closed	-$529K	–	87
2016 Q2	$529K	Sell	6,350 -1,450	-19%	-$129K	0.23%	60
2016 Q1	$717K	Sell	7,800 -1,150	-13%	-$104K	0.32%	53
2015 Q4	$906K	Sell	8,950 -3,100	-26%	-$323K	0.59%	44
2015 Q3	$1.18M	Buy	12,050 +5,550	+85%	+$616K	0.51%	43
2015 Q2	$761K	Sell	6,500 -3,350	-34%	-$366K	0.52%	45
2015 Q1	$967K	Sell	9,850 -1,100	-10%	-$112K	0.64%	39
2014 Q4	$1.03M	Buy	10,950 +2,600	+31%	+$269K	0.46%	41
2014 Q3	$889K	Buy	8,350 +4,750	+132%	+$465K	0.4%	42
2014 Q2	$298K	Buy	+3,600	New	+$280K	0.14%	76
2013 Q4	–	Sell	-1,600	Closed	-$101K	–	82
2013 Q3	$101K	Buy	+1,600	New	+$95.6K	0.06%	95

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Birinyi Associates's GILD Position: Q1 2026 in Review

Birinyi Associates reduced its Gilead Sciences (GILD) stake by 18% in Q1 2026, selling an estimated $50.6K and leaving 1,600 shares worth $223K. The position accounts for 0.06% of the portfolio, ranked #59.

Birinyi Associates first reported a position in GILD in Q3 2013 and has held it in 12 quarters since. The position peaked at $1.18M in Q3 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Birinyi Associates held 1,600 shares of Gilead Sciences worth $223K as of Q1 2026.
Birinyi Associates sold 361 Gilead Sciences shares in Q1 2026, an estimated $50.6K.
Gilead Sciences made up 0.06% of Birinyi Associates's portfolio in Q1 2026, its #59 holding.
Birinyi Associates first reported a position in Gilead Sciences in Q3 2013 and has held it in 12 quarters since.
Birinyi Associates's Gilead Sciences position peaked at $1.18M in Q3 2015.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Birinyi Associates's 13F filing for Q1 2026, filed 4 May 2026.